The Food and Drug Administration is hosting the 2016 FDA Naloxone App Competition (#naloxoneapp) to encourage computer programmers, public health advocates, clinical researchers, entrepreneurs and...
Marvin Yingbin Ouyang, Ph.D., vice president of technology at Cyagen Biosciences, Inc., will present "CRISPR/Cas9 and TurboKnockout: Technologies for rapid generation of knockout/knockin mouse...
The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the funding of three research awards through its Biomedical Innovation Program. The program cultivates and...
You may have read that a drug from an OHSU startup received FDA approval last month. In 2003, OHSU's office of Technology Transfer & Business Development (TTBD) created a start-up company called...
The Oregon Bio 2014 Annual Conference highlights exciting trends and opportunities that are emerging in Oregon’s bioscience community. The overarching mission of the Oregon Bioscience Association...
The office of Technology Transfer & Business Development would like to highlight a particularly innovative or noteworthy OHSU innovator and invention at the university. This Fall 2014 quarter,...
The Oregon Clinical & Translational Research Institute (OCTRI) is pleased to announce the funding of four research awards through its Biomedical Innovation Program. The Program cultivates and...
OHSU Technology Transfer & Business Development interns provide a valuable service by assisting with technology development and the transition of technology from laboratory to market for the...
Check out the latest news in the office of Technology Transfer & Business Development (TTBD) In this issue, we discuss: OHSU’s partnership with the Allegory Venture Partners – Learn...
Barry Oken, M.D., professor of neurology and behavioral neuroscience in the OHSU School of Medicine, is the author of an article that was chosen as the May 2014 Editor’s Choice Article in the...